 |
市场调查报告书
商品编码
1983133
牛疫苗市场：依疫苗类型、疾病适应症、牛类型、给药途径、最终用户、分销管道和地区划分。Cattle Vaccine Market, By Vaccine Type, By Disease Indication, By Cattle Type, By Route of Administration, By End User, By Distribution Channel, By Geography |
||||||
预计到2026年，牛疫苗市场规模将达到41.3亿美元，到2033年将达到61.7亿美元。预计从2026年到2033年，其复合年增长率将达到5.9%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年： | 2025 | 2026年市场规模： | 41.3亿美元 |
| 历史数据时期： | 2020年至2024年 | 预测期： | 2026年至2033年 |
| 2026年至2033年预测期间的复合年增长率： | 5.90% | 2033年市场规模预测： | 61.7亿美元 |
全球牛疫苗市场是兽医医疗产业的关键领域，涵盖了旨在预防全球牛感染疾病的各种免疫生物产品。
随着畜牧业不断发展，越来越重视动物健康和福利，牛疫苗已成为维持牛群免疫力和确保农业永续生产力的重要手段。这些疫苗可以保护牛隻免受多种细菌、病毒和寄生虫疾病的侵害，包括牛呼吸道疾病复合体、牛、布氏桿菌症、炭疽病和梭状菌感染。
市面上的疫苗种类繁多，包括减毒活病毒疫苗、灭活疫苗、次单位疫苗和重组疫苗，每种疫苗都适用于特定的治疗用途和给药通讯协定。随着世界人口的增长和对富含蛋白质食物的需求增加，牛正在迅速扩张，因此，强有力的疾病预防策略至关重要。
该市场的特点是疫苗研发技术的不断进步，包括新型佐剂、改进的给药系统以及具有更广泛预防效果的联合疫苗。虽然区域法规结构确保了疫苗的安全性和有效性，但兽医专业人员和畜牧养殖户越来越认识到预防性保健措施比被动治疗方法更具经济效益，因此牛疫苗已成为现代畜牧业实践中不可或缺的一部分。
市场动态
全球牛疫苗市场受多种强劲因素驱动，持续成长。其中最主要的驱动因素是全球对牛肉和乳製品的需求不断增长，这推动了牛数量的增加，并促使人们采用集约化畜牧养殖方式，而这种方式需要全面的疾病预防策略。此外，人们对通用感染疾病及其从牛传播给人类的可能性认识不断提高，也促使人们更加关注牲畜疫苗接种计划，尤其是在畜牧业是重要经济活动的发展中地区。
疫苗研发的技术进步，包括标记疫苗、耐热配方和无针给药系统的引入，正在提高疫苗的功效和便利性，并提高畜牧养殖户的采用率。
政府对动物健康计画的倡议和监管支持，以及兽医保健支出的成长，正在进一步加速市场扩张。然而，也存在诸多限制因素。例如，疫苗研发和监管核准流程的高昂成本可能会限制价格敏感型市场的进入。此外，低温运输储存要求也带来了物流方面的挑战，尤其是在基础设施不足的偏远农业地区。
此外，一些畜牧养殖户对疫苗接种的犹豫、对潜在副作用的担忧以及其他疾病控制方法的存在，都可能阻碍疫苗的市场渗透。儘管如此，新兴国家畜牧业的扩张、精准农业技术的日益普及以及人们对有机和无抗生素肉类生产的日益关注，都带来了巨大的商机。利用重组DNA技术和奈米技术平台开发的新一代疫苗展现出良好的盈利，而疫苗生产商与畜牧养殖户之间的策略合作正在开闢新的市场管道并加强分销网络。
本次调查的主要特点。
- 本报告对全球牛疫苗市场进行了详细分析，给出了预测期（2026-2033 年）的市场规模（以十亿美元计）和复合年增长率（CAGR%），其中 2025 年为基准年。
- 该报告揭示了各个细分市场的潜在商机，并说明了该市场中一系列有吸引力的投资提案。
- 此外，本研究还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
- 本报告根据以下参数对全球牛疫苗市场的主要企业进行了分析：公司概况、产品系列、主要亮点、财务绩效和策略。
- 透过利用本报告中的见解，企业负责人和经营团队将能够就未来的产品发布、产品类型升级、市场扩张和行销策略做出明智的决策。
- 本报告面向该产业的各类相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
- 透过分析全球牛疫苗市场中使用的各种策略矩阵，相关人员将能够更轻鬆地做出决策。
目录
第一章：研究目标与前提条件
- 研究目标
- 前提
- 简称
第二章 市场范围
- 报告摘要
- 市场定义和范围
- 执行摘要
第三章：市场动态、监管与趋势分析
- 市场动态
- 影响分析
- 主要亮点
- 法规环境
- 产品上市及核准
- PEST分析
- 波特的分析
- 市场机会
- 法规环境
- 主要进展
- 产业趋势
第四章 全球牛疫苗市场：依疫苗类型划分，2021-2033年
- 联合（多价）疫苗
- 灭活（死菌）疫苗
- 减毒活病毒疫苗
- 重组疫苗
- 类毒素疫苗
- DNA/载体疫苗
第五章 全球牛疫苗市场：依疾病适应症划分，2021-2033年
- 牛呼吸道疾病（BRD复合体、IBR、BRSV、PI3）
- 口蹄疫
- 梭状菌感染（黑腿病、肠毒血症、破伤风）
- 牛病毒性腹泻（BVD）
- 钩端螺旋体病
- 乳腺炎
- 布氏桿菌症
- 炭疽病
- 其他疾病（例如约翰氏症和蓝舌病）
第六章 全球牛疫苗市场：依牛的种类划分，2021-2033年
- 牛
- 牛
- 种牛
- 牛/牛
第七章 全球牛疫苗市场：依给药途径划分，2021-2033年
- 注射疫苗
- 经鼻吸入型疫苗
- 口服疫苗
第八章 全球牛疫苗市场：依最终用户划分，2021-2033年
- 商业酪农
- 牛养殖场和牧场
- 兽医医院和诊所
- 政府和机构主导的疫苗接种计划
第九章 全球牛疫苗市场：依通路划分，2021-2033年
- 直接销售（从製造商到农场/机构）
- 兽医医院和诊所
- 动物用药品药局和批发商
- 政府采购计划
第十章 全球牛疫苗市场：依地区划分，2021-2033年
- 北美洲
- 我们
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 欧洲
- 德国
- 英国
- 西班牙
- 法国
- 义大利
- 俄罗斯
- 其他欧洲国家
- 亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- ASEAN
- 亚太其他地区
- 中东
- 海湾合作委员会国家
- 以色列
- 其他中东国家
- 非洲
- 南非
- 北非
- 中非
第十一章 竞争格局
- Zoetis
- Boehringer Ingelheim Animal Health
- Merck Animal Health MSD Animal Health
- Elanco Animal Health
- Ceva Sante Animale
- HIPRA
- Virbac
- Vaxxinova
- IDT Biologika
- Biogenesis Bago
- Indian Immunologicals Ltd
- Hester Biosciences Limited
- Jinyu Bio-Technology Co Ltd
- China Animal Husbandry Industry Co Ltd CAHIC
- Bioveta as International
第十二章 分析师建议
- 机会
- 分析师意见
- Coherent Opportunity Map
第十三章 参考文献与调查方法
- 参考
- 调查方法
- 关于本公司
Cattle Vaccine Market is estimated to be valued at USD 4.13 Bn in 2026 and is expected to reach USD 6.17 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 4.13 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.90% | 2033 Value Projection: | USD 6.17 Bn |
The global cattle vaccine market represents a critical segment of the veterinary healthcare industry, encompassing a comprehensive range of immunobiological products designed to prevent infectious diseases in cattle populations worldwide.
As livestock farming continues to evolve with increasing emphasis on animal health and welfare, cattle vaccines have become indispensable tools for maintaining herd immunity and ensuring sustainable agricultural productivity. These vaccines protect cattle against various bacterial, viral, and parasitic diseases including bovine respiratory disease complex, foot-and-mouth disease, brucellosis, anthrax, and clostridial infections, among others.
The market encompasses multiple vaccine types including live attenuated, inactivated, subunit, and recombinant vaccines, each serving specific therapeutic purposes and administration protocols. With the global population surge driving increased demand for protein-rich food sources, cattle farming operations are scaling up significantly, necessitating robust disease prevention strategies.
The market is characterized by continuous technological advancements in vaccine development, including novel adjuvants, improved delivery systems, and combination vaccines that offer broader protection spectrums. Regulatory frameworks across different regions ensure vaccine safety and efficacy, while veterinary professionals and livestock producers increasingly recognize the economic benefits of preventive healthcare measures over reactive treatment approaches, positioning cattle vaccines as essential components of modern animal husbandry practices.
Market Dynamics
The global cattle vaccine market is propelled by several compelling drivers that underscore its sustained growth trajectory. The primary driver stems from the escalating global demand for beef and dairy products, necessitating larger cattle populations and intensive farming practices that require comprehensive disease prevention strategies. Rising awareness about zoonotic diseases and their potential transmission from cattle to humans has intensified focus on livestock immunization programs, particularly in developing regions where cattle farming constitutes a significant economic activity.
Technological advancements in vaccine development, including the introduction of marker vaccines, thermostable formulations, and needle-free delivery systems, have enhanced vaccine efficacy and convenience, driving adoption rates among livestock producers.
Government initiatives and regulatory support for animal health programs, coupled with increasing veterinary healthcare expenditure, further accelerate market expansion. However, the market faces notable restraints including the high cost of vaccine development and regulatory approval processes, which can limit accessibility in price-sensitive markets. Cold chain storage requirements pose logistical challenges, particularly in remote agricultural regions with inadequate infrastructure.
Additionally, vaccine hesitancy among some livestock producers, concerns about potential adverse reactions, and the availability of alternative disease management approaches can impede market penetration. Nevertheless, significant opportunities emerge from expanding cattle farming operations in emerging economies, increasing adoption of precision livestock farming technologies, and growing emphasis on organic and antibiotic-free meat production. The development of next-generation vaccines utilizing recombinant DNA technology and nanotechnology platforms presents lucrative prospects, while strategic partnerships between vaccine manufacturers and livestock producers create new market channels and enhance distribution networks.
Key Features of the Study
- This report provides in-depth analysis of the global cattle vaccine market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global cattle vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Zoetis, Boehringer Ingelheim Animal Health, Merck Animal Health MSD Animal Health, Elanco Animal Health, Ceva Sante Animale, HIPRA, Virbac, Vaxxinova, IDT Biologika, Biogenesis Bago, Indian Immunologicals Ltd, Hester Biosciences Limited, Jinyu Bio-Technology Co Ltd, China Animal Husbandry Industry Co Ltd CAHIC, and Bioveta a.s. International
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global cattle vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cattle vaccine market
Market Segmentation
- Vaccine Type Insights (Revenue, USD Bn, 2021 - 2033)
- Combination (Multivalent) Vaccines
- Inactivated (Killed) Vaccines
- Live Attenuated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- DNA / Vector-Based Vaccines
- Disease Indication Insights (Revenue, USD Bn, 2021 - 2033)
- Bovine Respiratory Diseases (BRD Complex, IBR, BRSV, PI3)
- Foot and Mouth Disease (FMD)
- Clostridial Diseases (Blackleg, Enterotoxemia, Tetanus)
- Bovine Viral Diarrhea (BVD)
- Leptospirosis
- Mastitis
- Brucellosis
- Anthrax
- Others (Johne's disease, Bluetongue, etc.)
- Cattle Type Insights (Revenue, USD Bn, 2021 - 2033)
- Dairy Cattle
- Beef Cattle
- Breeding Stock
- Calves / Young Stock
- Route of Administration Insights (Revenue, USD Bn, 2021 - 2033)
- Injectable Vaccines
- Intranasal Vaccines
- Oral Vaccines
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Commercial Dairy Farms
- Beef Farms & Ranches
- Veterinary Clinics & Hospitals
- Government & Institutional Vaccination Programs
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Direct Sales (Manufacturers to Farms/Institutions)
- Veterinary Hospitals & Clinics
- Veterinary Pharmacies & Distributors
- Government Procurement Programs
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Zoetis
- Boehringer Ingelheim Animal Health
- Merck Animal Health MSD Animal Health
- Elanco Animal Health
- Ceva Sante Animale
- HIPRA
- Virbac
- Vaxxinova
- IDT Biologika
- Biogenesis Bago
- Indian Immunologicals Ltd
- Hester Biosciences Limited
- Jinyu Bio-Technology Co Ltd
- China Animal Husbandry Industry Co Ltd CAHIC
- Bioveta a.s. International
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Cattle Vaccine Market, By Vaccine Type
- Global Cattle Vaccine Market, By Disease Indication
- Global Cattle Vaccine Market, By Cattle Type
- Global Cattle Vaccine Market, By Route of Administration
- Global Cattle Vaccine Market, By End User
- Global Cattle Vaccine Market, By Distribution Channel
- Global Cattle Vaccine Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trends
4. Global Cattle Vaccine Market, By Vaccine Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Combination (Multivalent) Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Inactivated (Killed) Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Live Attenuated Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Recombinant Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Toxoid Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- DNA / Vector-Based Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Cattle Vaccine Market, By Disease Indication, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Bovine Respiratory Diseases (BRD Complex, IBR, BRSV, PI3)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Foot and Mouth Disease (FMD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Clostridial Diseases (Blackleg, Enterotoxemia, Tetanus)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Bovine Viral Diarrhea (BVD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Leptospirosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Mastitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Brucellosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Anthrax
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others (Johne's disease, Bluetongue, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Cattle Vaccine Market, By Cattle Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Dairy Cattle
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Beef Cattle
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Breeding Stock
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Calves / Young Stock
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Cattle Vaccine Market, By Route of Administration, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Injectable Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Intranasal Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Oral Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Cattle Vaccine Market, By End User, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Commercial Dairy Farms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Beef Farms & Ranches
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Veterinary Clinics & Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Government & Institutional Vaccination Programs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
9. Global Cattle Vaccine Market, By Distribution Channel, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Direct Sales (Manufacturers to Farms/Institutions)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Veterinary Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Veterinary Pharmacies & Distributors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Government Procurement Programs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
10. Global Cattle Vaccine Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Cattle Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Cattle Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Cattle Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Cattle Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Cattle Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Cattle Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Zoetis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boehringer Ingelheim Animal Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck Animal Health MSD Animal Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Elanco Animal Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ceva Sante Animale
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- HIPRA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Virbac
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vaxxinova
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- IDT Biologika
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biogenesis Bago
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Indian Immunologicals Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hester Biosciences Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Jinyu Bio-Technology Co Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- China Animal Husbandry Industry Co Ltd CAHIC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bioveta a.s. International
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
兽用抗生素市场：按类别、动物类型、最终用户和治疗领域划分－全球预测，2026-2032年全球畜牧育种市场（按品种、育种目的、育种系统和技术以及分销管道划分）预测（2026-2032年）兽用角膜护理镜片市场（依动物种类、产品类型、通路和应用划分）－全球预测，2026-2032年
骆驼痘疫苗市场规模、份额和成长分析：按产品类型、传播途径、检测方法、应用、最终用户和地区划分－2026-2033年产业预测
伴侣动物疫苗市场分析及预测（至2035年）：类型、产品、技术、应用、最终用户、功能、服务、部署、材料类型、阶段兽用抗生素市场分析及预测（至2035年）：类型、产品、应用、剂型、最终用户、技术、功能与服务兽用疫苗市场分析及预测（至2035年）：类型、产品类型、技术、应用、最终用户、剂型、组成成分、阶段、安装类型
2026-2034年牛暂缓发热疫苗全球市场规模、份额、趋势和成长分析报告兽用疫苗全球市场规模、份额、趋势和成长分析报告（2026-2034）畜牧疫苗市场规模、份额、成长率及全球市场分析：按类型、应用和地区划分，并预测至2026-2034年